These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 20585226)
21. Handling missing data: a commonly encountered problem in quantitative research. Duffy ME Clin Nurse Spec; 2006; 20(6):273-6. PubMed ID: 17149015 [No Abstract] [Full Text] [Related]
22. Different methods to analyze stepped wedge trial designs revealed different aspects of intervention effects. Twisk JW; Hoogendijk EO; Zwijsen SA; de Boer MR J Clin Epidemiol; 2016 Apr; 72():75-83. PubMed ID: 26586107 [TBL] [Abstract][Full Text] [Related]
23. Repeated Measures Designs and Analysis of Longitudinal Data: If at First You Do Not Succeed-Try, Try Again. Schober P; Vetter TR Anesth Analg; 2018 Aug; 127(2):569-575. PubMed ID: 29905618 [TBL] [Abstract][Full Text] [Related]
24. A Data Analysis Method for Using Longitudinal Binary Outcome Data from a SMART to Compare Adaptive Interventions. Dziak JJ; Yap JRT; Almirall D; McKay JR; Lynch KG; Nahum-Shani I Multivariate Behav Res; 2019; 54(5):613-636. PubMed ID: 30663401 [TBL] [Abstract][Full Text] [Related]
25. Model inconsistency, illustrated by the Cox proportional hazards model. Ford I; Norrie J; Ahmadi S Stat Med; 1995 Apr; 14(8):735-46. PubMed ID: 7644855 [TBL] [Abstract][Full Text] [Related]
27. Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures. Gosho M; Maruo K Pharm Stat; 2018 Sep; 17(5):578-592. PubMed ID: 29978944 [TBL] [Abstract][Full Text] [Related]
29. Analysis of longitudinal randomized clinical trials using item response models. Glas CA; Geerlings H; van de Laar MA; Taal E Contemp Clin Trials; 2009 Mar; 30(2):158-70. PubMed ID: 19146991 [TBL] [Abstract][Full Text] [Related]
30. MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a "de jure" estimand. García-Hernandez A; Pérez T; Pardo MDC; Rizopoulos D Pharm Stat; 2020 Nov; 19(6):909-927. PubMed ID: 32725810 [TBL] [Abstract][Full Text] [Related]
31. Multilevel analysis in public health research. Diez-Roux AV Annu Rev Public Health; 2000; 21():171-92. PubMed ID: 10884951 [TBL] [Abstract][Full Text] [Related]
34. Research considerations: power analysis and effect size. Connelly LM Medsurg Nurs; 2008 Feb; 17(1):41-2. PubMed ID: 18429540 [No Abstract] [Full Text] [Related]
35. Model selection techniques for the covariance matrix for incomplete longitudinal data. Grady JJ; Helms RW Stat Med; 1995 Jul; 14(13):1397-416. PubMed ID: 7481180 [TBL] [Abstract][Full Text] [Related]
36. Tweedie family of generalized linear models with distribution-free random effects for skewed longitudinal data. Ma R; Yan G; Hasan MT Stat Med; 2018 Oct; 37(24):3519-3532. PubMed ID: 29888505 [TBL] [Abstract][Full Text] [Related]
37. An introduction to latent growth curve modelling for longitudinal continuous data in dental research. Tu YK; D'Aiuto F; Baelum V; Gilthorpe MS Eur J Oral Sci; 2009 Aug; 117(4):343-50. PubMed ID: 19627343 [TBL] [Abstract][Full Text] [Related]
38. Complex sampling designs and statistical issues in secondary analysis. Kneipp SM; Yarandi HN West J Nurs Res; 2002 Aug; 24(5):552-66. PubMed ID: 12148835 [TBL] [Abstract][Full Text] [Related]
39. Joint analysis of longitudinal data with informative right censoring. Liu M; Ying Z Biometrics; 2007 Jun; 63(2):363-71. PubMed ID: 17425632 [TBL] [Abstract][Full Text] [Related]